News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,118 Results
Type
Article (40938)
Company Profile (294)
Press Release (652886)
Section
Business (206034)
Career Advice (2021)
Deals (35676)
Drug Delivery (85)
Drug Development (81176)
Employer Resources (168)
FDA (16220)
Job Trends (14996)
News (347922)
Policy (32895)
Tag
Academia (2612)
Alliances (49892)
Alzheimer's disease (1241)
Approvals (16151)
Artificial intelligence (131)
Bankruptcy (356)
Best Places to Work (11608)
Biotechnology (208)
Breast cancer (120)
Cancer (1094)
Cardiovascular disease (99)
Career advice (1689)
Cell therapy (234)
Clinical research (64441)
Collaboration (390)
Compensation (200)
COVID-19 (2580)
C-suite (96)
Data (1129)
Diabetes (152)
Diagnostics (6310)
Earnings (85263)
Employer resources (146)
Events (110274)
Executive appointments (311)
FDA (16760)
Funding (359)
Gene therapy (179)
GLP-1 (588)
Government (4373)
Healthcare (18804)
Infectious disease (2666)
Inflammatory bowel disease (107)
Interviews (312)
IPO (16374)
Job creations (3746)
Job search strategy (1444)
Layoffs (415)
Legal (7971)
Lung cancer (173)
Manufacturing (177)
Medical device (13239)
Medtech (13244)
Mergers & acquisitions (19382)
Metabolic disorders (404)
Neuroscience (1516)
NextGen Class of 2024 (6537)
Non-profit (4520)
Northern California (1484)
Obesity (233)
Opinion (182)
Patents (102)
People (56907)
Phase I (20029)
Phase II (28366)
Phase III (21155)
Pipeline (460)
Postmarket research (2575)
Preclinical (8611)
Radiopharmaceuticals (237)
Rare diseases (220)
Real estate (6100)
Regulatory (21827)
Research institute (2372)
Resumes & cover letters (350)
Southern California (1308)
Startups (3608)
United States (13579)
Vaccines (553)
Weight loss (169)
Date
Today (43)
Last 7 days (673)
Last 30 days (3708)
Last 365 days (35893)
2024 (32946)
2023 (40334)
2022 (51426)
2021 (56016)
2020 (54495)
2019 (46962)
2018 (35323)
2017 (32506)
2016 (31974)
2015 (38000)
2014 (31857)
2013 (26979)
2012 (29100)
2011 (29777)
2010 (27816)
Location
Africa (729)
Arizona (194)
Asia (37926)
Australia (6198)
California (3345)
Canada (1299)
China (252)
Colorado (149)
Connecticut (153)
Europe (81518)
Florida (461)
Georgia (117)
Illinois (343)
Indiana (197)
Kansas (96)
Maryland (581)
Massachusetts (2615)
Michigan (158)
Minnesota (278)
New Jersey (964)
New York (969)
North Carolina (718)
Northern California (1484)
Ohio (140)
Pennsylvania (849)
South America (1121)
Southern California (1308)
Texas (470)
Utah (92)
Washington State (365)
694,118 Results for "prometheus laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Business
Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing
Prometheus Laboratories Inc. today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser therapeutic drug monitoring (TDM) services for eligible patients receiving the Fresenius Kabi biosimilar, IDACIO (adalimumab-aacf).
August 1, 2023
·
3 min read
Press Releases
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
November 14, 2024
·
6 min read
Biotech Beach
Prometheus Laboratories Announces the Launch of PredictrPK ADA, A Precision-Guided Dosing Test for Optimization of Adalimumab
Prometheus Laboratories Inc. announced the launch of PredictrPK ADA, a precision-guided dosing test for adult Crohn’s disease (CD) patients receiving ADA treatment.
July 27, 2023
·
4 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
Deals
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.
April 16, 2023
·
12 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Biotech Bay
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
bioLytical Laboratories Inc., a global leader in rapid diagnostic tests, proudly announces the immediate availability of its INSTI® HCV Antibody Test in the Australian market.
May 19, 2024
·
4 min read
1 of 69,412
Next
